Peregrine Capital Management LLC Sells 6,929 Shares of Cabot Corporation $CBT

Peregrine Capital Management LLC trimmed its position in shares of Cabot Corporation (NYSE:CBTFree Report) by 8.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 72,219 shares of the specialty chemicals company’s stock after selling 6,929 shares during the quarter. Peregrine Capital Management LLC owned 0.14% of Cabot worth $5,439,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in CBT. Norges Bank bought a new stake in shares of Cabot in the 4th quarter worth about $49,662,000. AQR Capital Management LLC boosted its stake in shares of Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after purchasing an additional 478,702 shares during the period. UBS Group AG grew its holdings in Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after purchasing an additional 386,514 shares during the last quarter. Pacer Advisors Inc. raised its position in Cabot by 3,165.7% in the 4th quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after purchasing an additional 222,232 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Cabot in the 4th quarter worth about $8,785,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CBT. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. UBS Group increased their price target on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Truist Financial initiated coverage on Cabot in a research note on Monday, June 8th. They set a “buy” rating and a $98.00 price target for the company. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Finally, JPMorgan Chase & Co. upped their price objective on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday, May 13th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $85.80.

View Our Latest Analysis on Cabot

Cabot Price Performance

Cabot stock opened at $86.69 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The stock has a market cap of $4.47 billion, a price-to-earnings ratio of 16.39, a price-to-earnings-growth ratio of 11.94 and a beta of 0.83. The firm has a 50-day moving average of $84.09 and a two-hundred day moving average of $76.27. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53.

Cabot (NYSE:CBTGet Free Report) last issued its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. During the same period last year, the company posted $1.90 earnings per share. The company’s quarterly revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, research analysts forecast that Cabot Corporation will post 6.34 earnings per share for the current year.

Cabot Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 29th were issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.2%. The ex-dividend date was Friday, May 29th. This is an increase from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio (DPR) is 35.73%.

Cabot Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.